AdvaMed Urges “Broad-Based Approach” To AHRQ Research
This article was originally published in The Gray Sheet
Executive Summary
AHRQ's comparative clinical effectiveness research, authorized by the Medicare Modernization Act, should invoke a broader range of data than most randomized controlled trials currently offer, AdvaMed contends
You may also be interested in...
Private Comparative Effectiveness Arbiter Is In Industry’s Interest – Attorney
Industry should develop a third-party comparative effectiveness review organization to preclude Congress from creating a similar body, Sidley Austin Brown & Wood partner Patrick Morrisey said Dec. 5
Private Comparative Effectiveness Arbiter Is In Industry’s Interest – Attorney
Industry should develop a third-party comparative effectiveness review organization to preclude Congress from creating a similar body, Sidley Austin Brown & Wood partner Patrick Morrisey said Dec. 5
FDA Women’s Health Director Susan Wood Resigns In Protest Over Plan B
FDA Women's Health Director Susan Wood resigned Aug. 31 in protest over the agency's handling of Barr's Plan B emergency contraceptive application